THERAPEUTIC AGENT FOR MENTAL RETARDATION OR AUTISM

摘要

Disclosed is a novel therapeutic agent effective for the treatment of mental retardation or autism. The therapeutic agent for mental retardation or autism contains at least one component selected from the group consisting of tipifarnib and lonafarnib as an active ingredient. The mental retardation includes memory impair, and the memory impair includes memory impair associated with the abnormality of Tsc1 gene and/or Tsc2 gene and epilepsy-induced memory impair. Also provided is a method for treating mental retardation or autism, the method including administering an effective amount of at least one component selected from the group consisting of tipifarnib and lonafarnib to a mental retardation or autism patient.